Investigative Site 210

München, Bavaria 80802

0 studies enrolling now · 1 studies all time

What they study most

Urticaria Chronic

Studies at this site

• A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials — Stopped early